NCT01165983View on ClinicalTrials.gov

The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and Diabetes

NACompletedINTERVENTIONAL

Enrollment

124

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

January 31, 2012

Conditions

Diabetes Type 2

Interventions

DRUG

Placebo

0mg tablet, taken orally for 12 weeks daily

DRUG

Aliskiren

150mg tablet, taken orally for 12 weeks daily

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Joslin Foot Center & Microcirculation Laboratory, Boston

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Beth Israel Deaconess Medical Center

OTHER